STRM.BIO
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
750 Main St, Cambridge, Massachusetts, 0...Phone Number
(617) 877-6816Website
strm.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About STRM.BIO
STRM.BIO is a pre-clinical biotechnology company located in Cambridge, MA, focused on leveraging extracellular vesicles (EVs) to improve gene therapy delivery. The company aims to provide simpler, safer, and more practical solutions for patients suffering from rare diseases around the globe. STRM.BIO is backed by visionary leadership and committed investors who recognize the potential of their innovative EV technology.Explore more
STRM.BIO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is STRM.BIO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if STRM.BIO had a recent Job posting/layoffs
Product Launch: Get notified when STRM.BIO launches new products
Congratulate Masked Content for being promoted to Masked Content at STRM.BIO
Funding: Get notified immidiatlly once STRM.BIO has new funding data
Check out if STRM.BIO is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on STRM.BIO recently announced quarterly report
STRM.BIO, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if STRM.BIO has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to STRM.BIO
Compare insights from companies similar to STRM.BIO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
STRM.BIO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
STRM.BIO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about STRM.BIO.
STRM.BIO financials insights
Gather financial insights about STRM.BIO, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Seed
$8M
STRM.BIO Tech Stack
A closer look at the technologies used by STRM.BIO
Most Recent Scoops
Funding
Funding
Person-Based
Person-Based
Executive Move
Executive Moves, Board of Directors
Executive Move
Board of Directors
STRM.BIO News & Media
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy
CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ -- STRM.BIO, a start-up biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced that it has been awarded a contract from the Advanced Research Projects Agency for Health (ARPA-H)...Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
Ginkgo Bioworks to apply its RNA construct design expertise to develop long-lived, tissue- specific, and highly potent in vivo CAR therapies for autoimmune diseases BOSTON, Oct. 23, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with STRM.BIO and the...STRM.BIO Presents First Preclinical Data on a Novel Bone Marrow/Hematopoietic Stem Cell-Targeted Extracellular Vesicle Delivery Platform for In Vivo Gene Therapy at ASH 2023
Megakaryocyte-derived EVs show preferential biodistribution to bone marrow, bypassing the liver Safety and tolerability data demonstrate the potential for repeat dosing BOSTON, Dec. 11, 2023 /PRNewswire/ -- STRM.BIO, a pre-clinical, VC-backed biotechnology company that is leveraging...STRM.BIO CEO Jonathan Thon, Ph.D. to Deliver the 2023 R. D. Zeigler Innovation Research Lecture Sponsored by the Versiti Blood Research Institute
BOSTON, Oct. 19, 2023 /PRNewswire/ -- STRM.BIO, a pre-clinical, VC-backed biotechnology company that is leveraging extracellular vesicles (EVs) to deliver gene therapies and developing new therapeutics for rare blood diseases, today announced that CEO Jonathan Thon, Ph.D. is the featured...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding STRM.BIO
Sign Up For FreeTo access detailed company insights
STRM.BIO is a pre-clinical biotechnology company located in Cambridge, MA, focused on leveraging extracellular vesicles (EVs) to improve gene therapy delivery. The company aims to provide simpler, safer, and more practical solutions for patients suffering from rare diseases around the globe. STRM.BIO is backed by visionary leadership and committed... Read More
